Skip to main content

OrthoPediatrics Corp. Establishes Direct Sales Organization in Germany

Written by Customer Service on . Posted in Public Companies.

WARSAW, Ind., Jan. 06, 2023 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the establishment of its direct sales organization in Germany. OrthoPediatrics GmbH, commencing operations on January 1, 2023. OrthoPediatrics’ first direct international organization represents an expanding commitment to support pediatric orthopedics in international markets.

“We are proud to establish OrthoPediatrics GmbH, which demonstrates our commitment to helping children across the globe,” said Mark Karshner, Senior Vice President of International Sales at OrthoPediatrics. “Having a direct organization in Germany will provide better insights on the unique needs of the pediatric community there, along with additional resources to meet the needs of our expanding customer base. With our growing presence we aim to enhance surgeon relationships and provide a deeper level of service that we believe will ultimately lead to better patient outcomes.”

For the past ten years, OrthoPediatrics has maintained a presence in Germany that has been supported by distributors and more recently, by a sales agent. With this new direct organization, OrthoPediatrics will be able to establish a deeper connection to the German pediatric orthopedic community, which represents one of the largest orthopedic markets in Europe. OrthoPediatrics GmbH will continue to support the Vereinigung für Kinderorthopädie (German Association for Pediatric Orthopedics) through workshops and grants focused on the education of pediatric orthopedic surgeons. OrthoPediatrics GmbH will offer the Company’s full range of products focused on trauma, deformity correction, and spinal deformities across Germany.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 46 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.